Skip to content
Peptide guide

Peptides for weight loss: what the evidence shows

The peptides for weight loss with strong evidence are prescription GLP-1 medicines like semaglutide and tirzepatide, with newer drugs such as retatrutide still in trials. Research peptides sold online for fat loss have little or no human evidence.

This article is educational, not medical advice. Talk with a qualified healthcare professional before using any medicine or peptide.

Which peptides for weight loss actually work?

The peptides proven to cause large weight loss in people are the gut-hormone medicines: semaglutide and tirzepatide, which are approved, and retatrutide and CagriSema, which are still investigational. Every other “fat loss peptide” sold online has weak or failed human evidence.

These medicines are peptides because they are short chains of amino acids built to copy natural hormones like GLP-1, GIP, glucagon and amylin.

Weight loss peptides compared

Average weight loss below comes from the main trial of each drug, at the highest strength studied, and isn’t a promise for any one person.

Peptide How it works Average weight loss in its main trial Status
Semaglutide (Wegovy) GLP-1 14.9% at 68 weeks (STEP 1) FDA-approved
Tirzepatide (Zepbound) GIP + GLP-1 20.9% at 72 weeks (SURMOUNT-1) FDA-approved
Retatrutide GIP + GLP-1 + glucagon 28.3% at 80 weeks (TRIUMPH-1) Investigational
Cagrilintide + semaglutide (CagriSema) Amylin + GLP-1 About 20% at 68 weeks (REDEFINE 1) Under FDA review
AOD-9604 Growth hormone fragment No meaningful loss vs placebo Failed trials
MOTS-c Mitochondrial peptide No human weight trials Research only
Tesamorelin GHRH Cuts belly fat in HIV lipodystrophy; not a weight loss drug Approved for that one use

How do GLP-1 weight loss peptides work?

They copy hormones your gut releases after eating, which tell the brain you’re full and slow how fast the stomach empties. People eat less without forcing themselves to, which is why the weight loss is much larger than with older diet pills.

Adding more hormone targets seems to add more weight loss: one target for semaglutide, two for tirzepatide and three for retatrutide.

What about research peptides for fat loss?

Peptides like AOD-9604, MOTS-c and growth hormone peptides are sold online for fat loss, but none has shown meaningful weight loss in a good human trial. AOD-9604 is the clearest example: it was developed as an obesity drug and failed its main 24-week trial in 536 people.

Most claims about them come from animal studies or personal stories.

Side effects of weight loss peptides

The GLP-1 family commonly causes nausea, vomiting, diarrhea and constipation, especially while the dose is being raised. Rarer but serious risks include pancreatitis, gallbladder problems and dehydration-related kidney injury.

Approved medicines have known risks listed on their labels. Research peptides don’t, and their quality isn’t checked; see peptide side effects for more.

Can you buy weight loss peptides legally?

Approved medicines like Wegovy and Zepbound are legal with a prescription. Compounded copies were allowed only during the shortages, which ended in 2024 and 2025, and in April 2026 the FDA proposed closing most remaining compounding of them.

“Research use only” products sold online aren’t approved for human use; see are peptides legal? for details.

Peptides in this article

  • Semaglutide: FDA-approved (Ozempic, Wegovy, Rybelsus) for diabetes, weight and heart risk
  • Tirzepatide: FDA-approved (Mounjaro, Zepbound) for diabetes, weight and sleep apnea
  • Retatrutide: Investigational weight-loss drug: not approved anywhere yet
  • Cagrilintide: Investigational: CagriSema under FDA review, not approved yet
  • AOD-9604: Research peptide: failed weight-loss trials; not approved for human use
  • Tesamorelin: FDA-approved (Egrifta) for excess belly fat in HIV lipodystrophy
  • MOTS-c: Research peptide: not approved for human use

Frequently asked questions

What is the best peptide for weight loss?

By trial results, tirzepatide currently produces the most weight loss of approved medicines, and retatrutide has produced even more in trials but isn't approved. The right choice depends on your health, side effects and cost, and needs a prescriber.

Do weight loss peptides work without diet and exercise?

The trials combined the medicines with diet and activity advice. The drugs reduce appetite, but lifestyle still affects how much weight is lost and kept off.

Do you regain weight after stopping weight loss peptides?

Usually, yes. Studies of semaglutide and tirzepatide found most people regained much of the lost weight within a year of stopping.

Are research peptides for weight loss safe?

Their safety is unknown. Products sold online as research chemicals aren't approved, and regulators have found wrong strengths and contamination in unapproved versions of weight loss drugs.

Sources

  1. Wilding et al. (2021), Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), New England Journal of Medicine
  2. Jastreboff et al. (2022), Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), New England Journal of Medicine
  3. AJMC (2026), Retatrutide Achieves Up to 30.3% Average Weight Loss in Phase 3 TRIUMPH-1 Trial
  4. Pharmaceutical Executive (2025), Novo Nordisk Submits NDA to FDA for CagriSema
  5. Misra (2013), Central and Peripheral Molecular Targets for Anti-Obesity Pharmacotherapy (AOD-9604 trial result)
  6. Medscape (2026), FDA Proposes End to Mass GLP-1 Compounding

Last updated .

More peptide articles